New York State Common Retirement Fund Assembly Biosciences, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$3.14 - $3.9 $828 - $1,029	-264 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.8 - $4.56 $76,896 - $92,276	-20,236 Reduced 98.71%	264 $1,000
Q1 2021 May 11, 2021	SELL	$4.33 - $6.63 $35,939 - $55,029	-8,300 Reduced 28.82%	20,500 $94,000
Q2 2020 Aug 07, 2020	BUY	$14.57 - $23.96 $80,135 - $131,780	5,500 Added 23.61%	28,800 $672,000
Q4 2018 Feb 08, 2019	BUY	$19.05 - $36.45 $59,055 - $112,995	3,100 Added 15.35%	23,300 $527,000
Q3 2018 Nov 07, 2018	SELL	$34.41 - $44.23 $66,755 - $85,806	-1,940 Reduced 8.76%	20,200 $750,000
Q2 2018 Aug 10, 2018	BUY	$39.21 - $50.29 $86,262 - $110,638	2,200 Added 11.03%	22,140 $868,000
Q1 2018 May 10, 2018	BUY	$41.7 - $64.16 $205,998 - $316,950	4,940 Added 32.93%	19,940 $980,000
Q2 2017 Aug 11, 2017	BUY	N/A	15,000	15,000 $310,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.